The advisory board of the Fraunhofer IBMT consists of high-quality physicians and scientists as well as decision-makers from industry and business, politics, local government and the current President of Saarland University and Saarland University of Applied Sciences. It advises the Institute's management and the Executive Board and evaluates the Institute's performance on an annual basis.
Members of the Board of Trustees, chaired by Mr. Bernd Pfeil are:
- Dr. Günter J. Bauer, CEO, Transimmune AG, Düsseldorf, Germany
- Dr. Andreas Ebneth, Turnhout, Belgium
- Armin Engel, Freelancer Facility Management in the Healthcare Sector, Berlin, Germany
- Dr. Stefan Frank, Senior Director Strategy & Enterprise Operations, BlueRock Therapeutics, Leverkusen, Germany
- Dr. med. Christine Günther, Partner at ViopasVenture Consulting GmbH Deutschland, Martinsreid, Germany
- Dr. Marike Kolossa-Gehring, Head of Department Toxicology, Health-Related Environmental Monitoring, Federal Environment Agency, Berlin, Germany
- Prof. Dr.-Ing. Dieter Leonhard, President of htw saar, Saarland University of Applied Sciences, Saarbrücken, Germany
- Dr. Jens Rosenbaum, Head of Research and Innovation Department, Saarland Ministry of Economic Affairs, Innovation, Digital and Energy, Saarbrücken, Germany
- Prof. Dr. Ludger Santen, President of Saarland University, Saarbrücken, Germany
- Prof. Dr. Laura Steenpaß, Chair of Cell Biology, Technical University of Braunschweig, Head of Department for Human and Animal Cell Cultures, Leibniz Institute DSMZ - German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany
- Ltd. MR Dr. Stefan Wimbauer, Department of Innovation, Research, Technology, Digitization, Head of Division Applied Research, Cluster Policy, Division 43, Deputy Head of Department, Bavarian State Ministry of Economic Affairs, Regional Development and Energy, Munich, Germany
Honorary advisory board member since 2015: Prof. Dr. José G. Esparza-Bracho, University of Maryland, School of Medicine, Baltimore, USA